G. Defossez, L. Guyader-peyrou, S. Uhry, Z. Grosclaude, P. Remontet et al., Estimations nationales de l'incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Résultats préliminaires, 2019.

S. Yang, T. Yang, K. C. Chen, Y. Li, K. Hsu et al., EGFR L858R Mutation and Polymorphisms of Genes Related to Estrogen Biosynthesis and Metabolism in Never-Smoking Female Lung Adenocarcinoma Patients, Clinical Cancer Research, vol.17, issue.8, pp.2149-2158, 2011.

A. L. Van-dyke, M. L. Cote, G. M. Prysak, G. B. Claeys, A. S. Wenzlaff et al., COX-2/EGFR expression and survival among women with adenocarcinoma of the lung, Carcinogenesis, vol.29, issue.9, pp.1781-1787, 2008.

S. Kligerman and C. White, Epidemiology of Lung Cancer in Women: Risk Factors, Survival, and Screening, American Journal of Roentgenology, vol.196, issue.2, pp.287-295, 2011.

H. Nakamura, K. Ando, T. Shinmyo, K. Morita, A. Mochizuki et al., Female Gender Is an Independent Prognostic Factor in Non-small-cell Lung Cancer: A Meta-analysis, Annals of Thoracic and Cardiovascular Surgery, vol.17, issue.5, pp.469-480, 2011.

J. B. Fu, T. Y. Kau, R. K. Severson, and G. P. Kalemkerian, Lung Cancer in Women, Chest, vol.127, issue.3, pp.768-777, 2005.

F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: A Cancer Journal for Clinicians, vol.68, issue.6, pp.394-424, 2018.

Z. Dantony, N. Bossard, L. Roche, L. Remontet, P. Grosclaude et al., Survie nette conditionnelle chez les personnes atteintes de cancer en France Métropolitaine, Étude réalisée à partir des données du réseau français des registres des cancers (FRANCIM), 2019.

M. Bardot and E. Chirpaz, Les Cancers à La Réunion, Tableau de Bord

R. Doll, R. Peto, J. Boreham, and I. Sutherland, Mortality in relation to smoking: 50 years' observations on male British doctors, BMJ, vol.328, issue.7455, p.1519, 2004.

D. Coëtmeur, G. Leveiller, V. Frappat, M. Martin, M. Peureux et al., Relation entre cancer bronchique primitif et consommation tabagique. Résultats de l?étude KBP-2010-CPHG du Collège des pneumologues des hôpitaux généraux, Revue des Maladies Respiratoires, vol.33, issue.7, pp.583-593, 2016.

F. Binder-foucard, N. Bossard, P. Delafosse, A. Belot, A. S. Woronoff et al., Cancer incidence and mortality in France over the 1980?2012 period: Solid tumors, Revue d'Épidémiologie et de Santé Publique, vol.62, issue.2, pp.95-108, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01915012

S. Couraud, P. J. Souquet, C. Paris, P. Dô, H. Doubre et al., BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers, European Respiratory Journal, vol.45, issue.5, pp.1403-1414, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02456986

D. M. Burns, C. M. Anderson, and N. Gray, Do changes in cigarette design influence the rise in adenocarcinoma of the lung?, Cancer Causes & Control, vol.22, issue.1, pp.13-22, 2010.

S. D. Stellman, J. E. Muscat, D. Hoffmann, and E. L. Wynder, Impact of Filter Cigarette Smoking on Lung Cancer Histology, Preventive Medicine, vol.26, issue.4, pp.451-456, 1997.

C. I. Henschke and O. S. Miettinen, Women?s susceptibility to tobacco carcinogens, Lung Cancer, vol.43, issue.1, pp.1-5, 2004.

S. Kligerman and C. White, Epidemiology of lung cancer in women: risk factors, survival, and screening, AJR Am J Roentgenol, vol.196, issue.2, pp.287-295, 2011.

C. Bain, D. Feskanich, F. E. Speizer, M. Thun, E. Hertzmark et al., Lung Cancer Rates in Men and Women With Comparable Histories of Smoking, JNCI Journal of the National Cancer Institute, vol.96, issue.11, pp.826-834, 2004.

R. Andler, J. Richard, V. Nguyen-thanh, and D. Baromètre, Tabagisme et usage d'e-cigarette, 2014.

F. Martin, Le cancer broncho-pulmonaire dans le département de La Réunion : caractéristiques cliniques et démographiques

T. Urban and J. Hureaux, Cannabis et poumon. Ce que l?on sait et tout ce que l?on ne sait pas, Revue de Pneumologie Clinique, vol.73, issue.6, pp.283-289, 2017.

O. Bylicki, F. Rivière, H. Lefloch, W. Gaspard, and J. Margery, Les formes familiales de cancers bronchiques, Revue des Maladies Respiratoires Actualités, vol.9, issue.2, pp.89-93, 2017.

A. Gazdar, L. Robinson, D. Oliver, C. Xing, W. D. Travis et al., Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations, Journal of Thoracic Oncology, vol.9, issue.4, pp.456-463, 2014.

S. Toyooka, T. Tsuda, and A. F. Gazdar, TheTP53 gene, tobacco exposure, and lung cancer, Human Mutation, vol.21, issue.3, pp.229-239, 2003.

M. L. Coté, M. Liu, S. Bonassi, M. Neri, A. G. Schwartz et al., Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium

A. Ullrich, 68 Targeted Cancer Therapy Development, European Journal of Cancer, vol.48, p.S16, 2012.

A. Cassidy, J. P. Myles, M. Van-tongeren, R. D. Page, T. Liloglou et al., The LLP risk model: an individual risk prediction model for lung cancer, British Journal of Cancer, vol.98, issue.2, pp.270-276, 2007.

S. Couraud, G. Zalcman, B. Milleron, F. Morin, and P. J. Souquet, Lung cancer in never smokers ? A review, European Journal of Cancer, vol.48, issue.9, pp.1299-1311, 2012.

D. R. Brenner, R. J. Hung, M. S. Tsao, F. A. Shepherd, M. R. Johnston et al., Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors, BMC Cancer, vol.10, issue.1, p.285, 2010.

G. V. Scagliotti, G. Selvaggi, and S. Novello, The biology of epidermal growth factor receptor in lung cancer, ClinCancer Res, vol.10, pp.4227-4259, 2004.

D. G. Guinee, W. D. Travis, G. E. Trivers, V. M. Benedetti, H. Cawley et al., Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression, Carcinogenesis, vol.16, issue.5, pp.993-1002, 1995.

C. C. Hseigh, K. C. Chow, and H. J. Fahn, Prognostic significance of Her-2/neu expression in Stage I adenocarcinoma of lung, Ann ThoracSurg, vol.66, pp.1159-63, 1998.

S. Dogan, R. Shen, D. C. Ang, M. L. Johnson, S. P. D'angelo et al., Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers, Clinical Cancer Research, vol.18, issue.22, pp.6169-6177, 2012.

C. Molina-romero, O. Arrieta, and R. Hernández-pando, Tuberculosis and lung cancer, Salud Pública de México, vol.61, issue.3, may-jun, p.286, 2019.

H. Y. Liang, X. L. Li, X. S. Yu, P. Guan, Z. H. Yin et al., Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: A systematic review, International Journal of Cancer, vol.125, issue.12, pp.2936-2944, 2009.

Y. H. Yu, C. C. Liao, W. H. Hsu, H. J. Chen, W. C. Liao et al., Increased Lung Cancer Risk among Patients with Pulmonary Tuberculosis: A Population Cohort Study, Journal of Thoracic Oncology, vol.6, issue.1, pp.32-37, 2011.

R. P. Young, R. J. Hopkins, T. Christmas, P. N. Black, P. Metcalf et al., COPD prevalence is increased in lung cancer, independent of age, sex and smoking history, European Respiratory Journal, vol.34, issue.2, pp.380-386, 2009.

C. Mouronte-roibás, V. Leiro-fernández, A. Fernández-villar, M. Botana-rial, C. Ramos-hernández et al., COPD, emphysema and the onset of lung cancer. A systematic review, Cancer Letters, vol.382, issue.2, pp.240-244, 2016.

V. J. Cogliano, R. Baan, K. Straif, Y. Grosse, B. Lauby-secretan et al., Preventable Exposures Associated With Human Cancers, JNCI Journal of the National Cancer Institute, vol.103, issue.24, pp.1827-1839, 2011.

D. W. Bleyl, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, ? s.Fr, Food / Nahrung, vol.33, issue.5, pp.462-462, 1989.

S. Sun, J. H. Schiller, and A. F. Gazdar, Lung cancer in never smokers ? a different disease, Nature Reviews Cancer, vol.7, issue.10, pp.778-790, 2007.

I. T. Yu, Y. L. Chiu, J. S. Au, T. W. Wong, and J. L. Tang, Dose-Response Relationship between Cooking Fumes Exposures and Lung Cancer among Chinese Nonsmoking Women, Cancer Research, vol.66, issue.9, pp.4961-4967, 2006.

A. V. Ramanakumar, M. E. Parent, and J. Siemiatycki, Risk of Lung Cancer from Residential Heating and Cooking Fuels in Montreal, Canada, American Journal of Epidemiology, vol.165, issue.6, pp.634-642, 2007.

G. A. Raspanti, M. Hashibe, B. Siwakoti, M. Wei, B. K. Thakur et al., Household air pollution and lung cancer risk among never-smokers in Nepal, Environmental Research, vol.147, pp.141-145, 2016.

J. C. Pairon, F. Delva, and P. Brochard, Quelle surveillance médicale après exposition à des cancérogènes pulmonaires professionnels ?, Rev Mal Resp, vol.9, issue.2, pp.94-99, 2017.

M. C. Alavanja1, M. Dosemeci, C. Samanic, J. Lubin, C. F. Lynch et al., USE OF AGRICULTURAL PESTICIDES AND LUNG CANCER RISK IN THE AGRICULTURAL HEALTH STUDY COHORT, Epidemiology, vol.15, issue.4, pp.S178-S179, 2004.

, Neuerscheinungen, Angewandte Chemie, vol.85, issue.19, pp.876-876, 1973.

. O-raaschou-nielsen, R. Andersen, . Beelen, E. Samoli, M. Stafoggia et al., Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE), Lancet Oncol, vol.14, pp.813-822, 2013.

T. A. Sellers, J. D. Potter, A. R. Folsom, and G. P. Vogler, Association of incident lung cancer with family history of female reproductive cancers: The Iowa women's health study, Genetic Epidemiology, vol.8, issue.3, pp.199-208, 1991.

C. T. Wu, Y. L. Chang, J. Y. Shih, and Y. C. Lee, The significance of estrogen receptor ? in 301 surgically treated non?small cell lung cancers, The Journal of Thoracic and Cardiovascular Surgery, vol.130, issue.4, pp.979-986, 2005.

B. G. Skov, B. M. Fischer, and H. Pappot, Oestrogen receptor ? over expression in males with non-small cell lung cancer is associated with better survival, Lung Cancer, vol.59, issue.1, pp.88-94, 2008.

A. Koushik, M. E. Parent, and J. Siemiatycki, Characteristics of menstruation and pregnancy and the risk of lung cancer in women, International Journal of Cancer, vol.125, issue.10, pp.2428-2433, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00819918

M. L. Liao, J. H. Wang, H. H. Wang, A. Q. Ou, X. H. Wang et al., A study of the association between squamous cell carcinoma and adenocarcinoma in the lung, and history of menstruation in Shanghai women, China, Lung Cancer, vol.14, issue.1, pp.S215-S221, 1996.

Y. Zhang, Z. Yin, L. Shen, Y. Wan, and B. Zhou, Menstrual factors, reproductive factors and lung cancer risk: A meta-analysis, Chin J Lung Cancer, vol.15, pp.701-719, 2012.

J. K. Paulus, K. Asomaning, P. Kraft, B. E. Johnson, X. Lin et al., Parity and Risk of Lung Cancer in Women, American Journal of Epidemiology, vol.171, issue.5, pp.557-563, 2010.

C. S. Baik, G. M. Strauss, F. E. Speizer, and D. Feskanich, Reproductive Factors, Hormone Use, and Risk for Lung Cancer in Postmenopausal Women, the Nurses' Health Study, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.10, pp.2525-2533, 2010.

J. Clague, P. Reynolds, J. Sullivan-halley, H. Ma, J. V. Lacey et al., Menopausal Hormone Therapy Does Not Influence Lung Cancer Risk: Results from the California Teachers Study, Cancer Epidemiology Biomarkers & Prevention, vol.20, issue.3, pp.560-564, 2011.

R. T. Chlebowski, G. L. Anderson, J. E. Manson, A. G. Schwartz, H. Wakelee et al., Lung Cancer Among Postmenopausal Women Treated With Estrogen Alone in the Women's Health Initiative Randomized Trial, JNCI: Journal of the National Cancer Institute, vol.102, issue.18, pp.1413-1421, 2010.

K. Y. Chen, C. F. Hsiao, G. C. Chang, Y. H. Tsai, W. C. Su et al., Hormone replacement therapy and lung cancer risk in Chinese, Cancer, vol.110, issue.8, pp.1768-1775, 2007.

D. Cruz, C. S. Tanoue, L. T. Matthay, and R. A. , Lung cancer: epidemiology, etiology, and prevention, Clin Chest Med, vol.32, pp.605-644, 2011.

F. L. Büchner, H. B. Bueno?de?mesquita, M. M. Ros, E. Kampman, and B. Kiemeney, Abstract B103: Quantity and variety of vegetable and fruit consumption and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC), Epidemiology/Lifestyle Factors, vol.19, pp.2278-2286, 2010.

M. Touvier, E. Kesse, F. Clavel-chapelon, and M. Boutron-ruault, Dual Association of ?-Carotene With Risk of Tobacco-Related Cancers in a Cohort of French Women, JNCI: Journal of the National Cancer Institute, vol.97, issue.18, pp.1338-1344, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00117451

G. S. Omenn, G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen et al., Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease, New England Journal of Medicine, vol.334, issue.18, pp.1150-1155, 1996.

D. Albanes, O. P. Heinonen, J. K. Huttunen, P. R. Taylor, J. Virtamo et al., Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study, The American Journal of Clinical Nutrition, vol.62, issue.6, pp.1427S-1430S, 1995.

J. B. Richard, Premiers résultats du Baromètre Santé DOM, 2014.

J. A. Barta, C. A. Powell, and J. P. Wisnivesky, Global Epidemiology of Lung Cancer, Annals of Global Health, vol.85, issue.1, pp.1-16, 2019.

E. A. Engels, M. V. Brock, J. Chen, C. M. Hooker, M. Gillison et al., Elevated Incidence of Lung Cancer Among HIV-Infected Individuals, Journal of Clinical Oncology, vol.24, issue.9, pp.1383-1388, 2006.

K. Sigel, J. Wisnivesky, K. Gordon, R. Dubrow, A. Justice et al., HIV as an independent risk factor for incident lung cancer, AIDS, vol.26, issue.8, pp.1017-1025, 2012.

L. Brouchet, S. Valmary, M. Dahan, A. Didier, F. Galateau-salle et al., Detection of oncogenic virus genomes and gene products in lung carcinoma, British Journal of Cancer, vol.92, issue.4, pp.743-746, 2005.

A. Midha, S. Dearden, and R. Mccormack, EGFR mutation incidence in nonsmall-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII), Am J Cancer Res, vol.5, issue.9, pp.2892-2911, 2015.

J. A. Pinto, C. S. Vallejos, L. E. Raez, L. A. Mas, R. Ruiz et al., Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?, ESMO Open, vol.3, issue.3, p.e000344, 2018.

F. Conforti, L. Pala, and V. Bagnardi, Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis, Lancet Oncol, vol.19, pp.737-783, 2018.

H. De-koning, C. Van-der-aalst, K. Ten-haaf, and M. Oudkerk, PL02.05 Effects of Volume CT Lung Cancer Screening: Mortality Results of the NELSON Randomised-Controlled Population Based Trial, Journal of Thoracic Oncology, vol.13, issue.10, p.S185, 2018.

, Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening, New England Journal of Medicine, vol.365, issue.5, pp.395-409, 2011.

C. Clément-duchêne, J. M. Vignaud, A. Stoufflet, O. Bertrand, A. Gislard et al., Characteristics of never smoker lung cancer including environmental and occupational risk factors, Lung Cancer, vol.67, issue.2, pp.144-150, 2010.

C. Taylor, C. Correa, F. K. Duane, M. C. Aznar, S. J. Anderson et al., Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials, Journal of Clinical Oncology, vol.35, issue.15, pp.1641-1649, 2017.

C. M. Greiser, E. M. Greiser, and M. Dören, Menopausal hormone therapy and risk of lung cancer?Systematic review and meta-analysis, Maturitas, vol.65, issue.3, pp.198-204, 2010.

J. M. Siegfried and L. P. Stabile, Estrogenic Steroid Hormones in Lung Cancer, Seminars in Oncology, vol.41, issue.1, pp.5-16, 2014.

D. Debieuvre, C. Lemonnier, J. M. Marcos, M. D?arlhac, S. Vuillermoz-blas et al., KBP-2010-CPHG : évolution de la survie à 5 ans des cancers bronchiques primitifs, Revue des Maladies Respiratoires, vol.34, p.A53, 2017.

. Résumé, Le cancer pulmonaire est une pathologie fréquente dans le monde, grave, représentant la première cause de décès par cancer. Son incidence dans la population féminine est en augmentation depuis plusieurs années en France métropolitaine et à La Réunion, le principal facteur de risque attribuable reste le tabac. Cependant, des facteurs environnementaux et génétiques ont été identifiés comme facteurs de risque, et des facteurs hormonaux sembleraient jouer un rôle dans l'oncogenèse bronchique. Dans la littérature, la survie des femmes atteintes serait meilleure que celle des hommes. Nous avons donc étudié la survie et les caractéristiques d'une cohorte rétrospective de 501 cas incidents, hommes et femmes à La Réunion, diagnostiqués d, Survie et caractéristiques épidémiologiques des femmes atteintes de cancer pulmonaire à La Réunion Introduction, p.31, 2018.

. Méthode, Cette étude rétrospective observationnelle multicentrique a été menée à partir d'un recueil de données basé sur les dossiers médicaux informatisés des patients nouvellement diagnostiqués d'un cancer pulmonaire à la Réunion sur la période et présentés en RCP dans les centres référents d'oncologie thoracique

, Dans la majorité des pays de l?OCDE, les femmes consacrent plus de temps aux relations sociales que les hommes, Résultats: 501 patients ont été inclus sur la période, dont 166 femmes. La médiane de survie globale était de 23 mois chez les femmes et de 11 mois chez les hommes tout type histologique et stade confondu (p<0,0005), 2020.

V. Chaillou-atrous, Saint-Denis de La Réunion dans la seconde moitié du XIXe siècle : un port de commerce et de transit des engagés africains, Les Européens dans les ports en situation coloniale, pp.107-131

J. Jones, Women Who Were More Than Men: Sex and Status in Freedmen?s Teaching, Social and Moral Reform, vol.45, p.0

L. T. Tanoue, Women With Pathologic Stage I, II, and III Non-small Cell Lung Cancer Have Better Survival Than Men, Yearbook of Pulmonary Disease, vol.2008, pp.104-105, 2008.